Dr. Cheng Chi Keung - General Practice
General Practice
Highlights
- MCHK RegisteredVerified
- 1 LocationsYuen Long Town
- QualificationsBachelor of Medicine and Bachelor of Surgery (MBBS) · Medical degree 1996
- InsuranceBeing compiled｜See details
About
Dr. Cheng Chi Keung practises General Practice in Yuen Long Town, Hong Kong.
Education
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1996
Locations
G/F, 146b On Ning Road, Yuen Long, NT
Get Directions →Weekly Hours
| Monday | 10:00 AM - 1:00 PM, 3:00 PM - 8:00 PM |
| Tuesday | 10:00 AM - 1:00 PM, 3:00 PM - 8:00 PM |
| Wednesday | Hours not available |
| Thursday | 10:00 AM - 1:00 PM, 3:00 PM - 8:00 PM |
| Friday | 10:00 AM - 1:00 PM, 3:00 PM - 8:00 PM |
| Saturday | 10:00 AM - 1:00 PM |
| Sunday | Hours not available |
Yuen Long Town
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Cheng Chi Keung? Claim page and update insurance →
FAQ
Is Dr. Cheng Chi Keung any good?
Dr. Cheng Chi Keung practises General Practice in Yuen Long Town, Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Cheng Chi Keung do?
Dr. Cheng Chi Keung practises in General Practice.
Where does Dr. Cheng Chi Keung practise?
Dr. Cheng Chi Keung practises at Yuen Long Town.
Is Dr. Cheng Chi Keung open on Saturdays?
Yes, Dr. Cheng Chi Keung has Saturday opening hours at Yuen Long Town.
Are you Dr. Cheng Chi Keung? Claim this page to update and manage.
ClaimResearch and publications
17 papers · 12 most recent shown
- Alpha-thalassaemia early eluting peak for alpha-thalassaemia --<sup>SEA</sup> carrier screening: a multicentre diagnostic comparison with immunochromatographic strip test and haemoglobin H inclusion test.Annals of hematology · 2026
- G3BP1::CSF1R: a new and actionable gene fusion in acute megakaryoblastic leukemia.Blood advances · 2025
- C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma.Blood advances · 2024
- Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia.Communications biology · 2023
- SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response.International journal of molecular sciences · 2023
- Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine.Blood cancer discovery · 2022
- A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia.Blood advances · 2022
- Mutational spectrum and prognosis in Chinese patients with prefibrotic primary myelofibrosis.EJHaem · 2022
- Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patients.HLA · 2021
- A novel F11 mutation in a Chinese paediatric patient with severe factor XI deficiency.Thrombosis research · 2020
- Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells.Journal of visualized experiments : JoVE · 2019
- RUNX1 upregulation via disruption of long-range transcriptional control by a novel t(5;21)(q13;q22) translocation in acute myeloid leukemia.Molecular cancer · 2018
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer